Cases
Experience: Venture Capital/Private Placements: $5,000,000 SAFE financing by blockchain.
$4,000,000 token purchase agreement
token warrant offering of blockchain company specializing in digital marketplace for anime content.
$2,000,000 simple agreement for future tokens (SAFT) financing by blockchain.
$50,000,000 cross-border corporate venture capital investment by leading Korean health care company into Series A venture financing of U.S. space
aeronautics company.
Aggregate $10,000,000 cross-border Series A venture capital investments by Singaporean fund into AI, health tech,
semiconductor IP licensing companies.
$3,000,000 conversion of SAFE held by corporate venture capital arm of leading automaker into Series B venture financing of technology company specializing in automaker software.
Aggregate $11,000,000 corporate venture capital investments by leading automaker in Series D venture financings of technology companies specializing in supply-chain networks.
$5,000,000 corporate venture capital investment by leading automaker in Series A venture financing of company specializing in self-driving automotive technology.
$2,500,000 corporate venture capital investment by leading automaker in Series B venture financing of technology company specializing in trucking industry.
$2,000,000 private placement of convertible notes of company specializing in wave semiconductor.
$1,500,000 private placement of convertible notes of company specializing in green market for carbon-tax credits.
$1,000,000 cross-border venture capital investment by Taiwanese electronics company in venture financing of AI imaging company.
$1,500,000 spinoff transaction by blockchain company of its
Aggregate $20,000,000 in private placements of convertible notes of public pharmaceutical company specializing in treatment of neurological disorders.
Aggregate $10,000,000 in private placements of common stock warrants of public pharmaceutical company specializing in treatment of neurological disorders.
Public Offerings: Cross-border de-SPAC transaction to result in listing of common stock
warrants of leading Zimbabwean gold mining company, valued at $500,000,000, on the Nasdaq Global Market.
Cross-border de-SPAC transaction to result in listing of common stock
warrants of leading Japanese chemical recycling company, valued at $300,000,000, on the NYSE (pending).
$19,000,000 cross-border IPO of common stock of a Japanese manufacturer of personal care products
spatial materials, led by Boustead Securities, LLC
Sutter Securities,, resulting in listing on the Nasdaq Capital Market.
Reverse takeover/merger transaction resulting in listing of common stock of medical technology company, valued at $110,000,000, on the Nasdaq Capital Market.
De-SPAC transaction resulting in listing of common stock
warrants of leading digital commerce platform for automotive aftermarket, valued at $250,000,000, on the NYSE American.
$140,000,000 at-the-market (ATM) offering program of leading provider of automotive LIDAR
$7,500,000 qualified offering under Regulation A of pharmaceutical company specializing in treatment of neurological disorders.
$2,000,000 equity line of credit of pharmaceutical company specializing in treatment of neurological
$525,000,000 senior notes offering of large international insurance company, led by RBC Capital Markets, Goldman Sachs & Co. LLC, Barclays, Credit Suisse,
US Bancorp.
$450,000,000 senior notes offering of large international insurance company, led by RBC Capital Markets, Goldman Sachs & Co. LLC, Credit Suisse,
US Bancorp.
$450,000,000 senior notes offering of large international insurance company, led by RBC Capital Markets, Goldman Sachs & Co. LLC, Barclays, Credit Suisse,
US Bancorp.
